Opti Capital Management, LP Quant / Systematic

Location: New York, NY

CIK: 0001738654 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $817M (0.0% shares, 100.0% debt)

Holdings (32)

— TESLA INC 17.7%

Value $145M Shares 20,962,000 Est. Cost $6.92 Unrealized —

— DOCUSIGN INC 10.3%

Value $84.51M Shares 27,933,000 Est. Cost $3.03 Unrealized —

— TERADYNE INC 9.5%

Value $77.81M Shares 30,439,000 Est. Cost $4.52 Unrealized —

— FIREEYE INC 5.3%

Value $43.28M Shares 44,390,000 Est. Cost $2.09 Unrealized —

— 8X8 INC NEW 5.2%

Value $42.24M Shares 45,450,000 Est. Cost $1.63 Unrealized —

— WAYFAIR INC 5.1%

Value $41.49M Shares 16,125,000 Est. Cost $3.92 Unrealized —

— VERINT SYS INC 4.8%

Value $39.3M Shares 38,646,000 Est. Cost $2.30 Unrealized —

— SUPERNUS PHARMACEUTICALS INC 4.7%

Value $38.71M Shares 41,818,000 Est. Cost $1.77 Unrealized —

— NUTANIX INC 4.6%

Value $37.63M Shares 39,969,000 Est. Cost $1.99 Unrealized —

— SYNAPTICS INC 3.8%

Value $31.09M Shares 25,000,000 Est. Cost $2.37 Unrealized —

— JAZZ INVESTMENTS I LTD 3.6%

Value $29.49M Shares 29,009,000 Est. Cost $2.00 Unrealized —

— NUANCE COMMUNICATIONS INC 3.4%

Value $27.55M Shares 18,904,000 Est. Cost $1.46 Unrealized —

— NEW RELIC INC 2.8%

Value $23.05M Shares 24,091,000 Est. Cost $1.46 Unrealized —

— AVAYA HLDGS CORP 2.5%

Value $20.75M Shares 22,000,000 Est. Cost $0.94 Unrealized —

— CYTOKINETICS INC 2.5%

Value $20.06M Shares 9,000,000 Est. Cost $4.95 Unrealized —

— RAMBUS INC DEL 1.7%

Value $14.14M Shares 13,500,000 Est. Cost $1.57 Unrealized —

— RAPID7 INC 1.6%

Value $13.27M Shares 8,500,000 Est. Cost $2.81 Unrealized —

— PTC THERAPEUTICS INC 1.2%

Value $9.674M Shares 8,500,000 Est. Cost $2.51 Unrealized —

— INTERCEPT PHARMACEUTICALS IN 1.1%

Value $9.34M Shares 13,246,000 Est. Cost $0.71 Unrealized —

— OMEROS CORP 1.1%

Value $8.648M Shares 9,200,000 Est. Cost $1.93 Unrealized —

— IRONWOOD PHARMACEUTICALS INC 0.9%

Value $7.747M Shares 7,800,000 Est. Cost $0.99 Unrealized —

— SAREPTA THERAPEUTICS INC 0.9%

Value $7.517M Shares 3,625,000 Est. Cost $2.07 Unrealized —

— OPKO HEALTH INC 0.9%

Value $7.096M Shares 6,000,000 Est. Cost $2.15 Unrealized —

— RETROPHIN INC 0.8%

Value $6.867M Shares 7,973,000 Est. Cost $1.69 Unrealized —

— GUIDEWIRE SOFTWARE INC 0.7%

Value $5.718M Shares 5,000,000 Est. Cost $1.14 Unrealized —

— THERAVANCE INC 0.6%

Value $5.002M Shares 5,200,000 Est. Cost $1.89 Unrealized —

— INSMED INC 0.5%

Value $4.371M Shares 4,000,000 Est. Cost $2.56 Unrealized —

— INFINERA CORP 0.5%

Value $4.186M Shares 4,500,000 Est. Cost $2.95 Unrealized —

— LIGAND PHARMACEUTICALS INC 0.5%

Value $4.093M Shares 4,500,000 Est. Cost $2.55 Unrealized —

— RADIUS HEALTH INC 0.5%

Value $3.807M Shares 4,625,000 Est. Cost $0.82 Unrealized —

— OMEROS CORP 0.4%

Value $2.941M Shares 3,500,000 Est. Cost $0.84 Unrealized —

— VONAGE HLDGS CORP 0.1%

Value $773K Shares 800,000 Est. Cost $0.97 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	TESLA INC	20,962,000	$145M	17.7%	$6.92	—	NOTE 2.000% 5/1	88160RAG6
—	DOCUSIGN INC	27,933,000	$84.51M	10.3%	$3.03	—	NOTE 0.500% 9/1	256163AB2
—	TERADYNE INC	30,439,000	$77.81M	9.5%	$4.52	—	NOTE 1.250%12/1	880770AG7
—	FIREEYE INC	44,390,000	$43.28M	5.3%	$2.09	—	NOTE 1.625% 6/0	31816QAD3
—	8X8 INC NEW	45,450,000	$42.24M	5.2%	$1.63	—	NOTE 0.500% 2/0	282914AB6
—	WAYFAIR INC	16,125,000	$41.49M	5.1%	$3.92	—	NOTE 1.125%11/0	94419LAD3
—	VERINT SYS INC	38,646,000	$39.3M	4.8%	$2.30	—	NOTE 1.500% 6/0	92343XAA8
—	SUPERNUS PHARMACEUTICALS INC	41,818,000	$38.71M	4.7%	$1.77	—	NOTE 0.625% 4/0	868459AD0
—	NUTANIX INC	39,969,000	$37.63M	4.6%	$1.99	—	NOTE 1/1	67059NAB4
—	SYNAPTICS INC	25,000,000	$31.09M	3.8%	$2.37	—	NOTE 0.500% 6/1	87157DAD1
—	JAZZ INVESTMENTS I LTD	29,009,000	$29.49M	3.6%	$2.00	—	NOTE 1.500% 8/1	472145AD3
—	NUANCE COMMUNICATIONS INC	18,904,000	$27.55M	3.4%	$1.46	—	DBCV 1.000%12/1	67020YAK6
—	NEW RELIC INC	24,091,000	$23.05M	2.8%	$1.46	—	NOTE 0.500% 5/0	64829BAB6
—	AVAYA HLDGS CORP	22,000,000	$20.75M	2.5%	$0.94	—	NOTE 2.250% 6/1	05351XAB7
—	CYTOKINETICS INC	9,000,000	$20.06M	2.5%	$4.95	—	NOTE 4.000%11/1	23282WAA8
—	RAMBUS INC DEL	13,500,000	$14.14M	1.7%	$1.57	—	NOTE 1.375% 2/0	750917AG1
—	RAPID7 INC	8,500,000	$13.27M	1.6%	$2.81	—	NOTE 1.250% 8/0	753422AB0
—	PTC THERAPEUTICS INC	8,500,000	$9.674M	1.2%	$2.51	—	NOTE 3.000% 8/1	69366JAB7
—	INTERCEPT PHARMACEUTICALS IN	13,246,000	$9.34M	1.1%	$0.71	—	NOTE 2.000% 5/1	45845PAB4
—	OMEROS CORP	9,200,000	$8.648M	1.1%	$1.93	—	NOTE 6.250%11/1	682143AE2
—	IRONWOOD PHARMACEUTICALS INC	7,800,000	$7.747M	0.9%	$0.99	—	NOTE 0.750% 6/1	46333XAF5
—	SAREPTA THERAPEUTICS INC	3,625,000	$7.517M	0.9%	$2.07	—	DBCV 1.500%11/1	803607AB6
—	OPKO HEALTH INC	6,000,000	$7.096M	0.9%	$2.15	—	NOTE 4.500% 2/1	68375NAD5
—	RETROPHIN INC	7,973,000	$6.867M	0.8%	$1.69	—	NOTE 2.500% 9/1	761299AB2
—	GUIDEWIRE SOFTWARE INC	5,000,000	$5.718M	0.7%	$1.14	—	NOTE 1.250% 3/1	40171VAA8
—	THERAVANCE INC	5,200,000	$5.002M	0.6%	$1.89	—	NOTE 2.125% 1/1	88338TAB0
—	INSMED INC	4,000,000	$4.371M	0.5%	$2.56	—	NOTE 1.750% 1/1	457669AA7
—	INFINERA CORP	4,500,000	$4.186M	0.5%	$2.95	—	NOTE 2.125% 9/0	45667GAC7
—	LIGAND PHARMACEUTICALS INC	4,500,000	$4.093M	0.5%	$2.55	—	NOTE 0.750% 5/1	53220KAF5
—	RADIUS HEALTH INC	4,625,000	$3.807M	0.5%	$0.82	—	NOTE 3.000% 9/0	750469AA6
—	OMEROS CORP	3,500,000	$2.941M	0.4%	$0.84	—	NOTE 5.250% 2/1	682143AG7
—	VONAGE HLDGS CORP	800,000	$773K	0.1%	$0.97	—	NOTE 1.750% 6/0	92886TAJ1